文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

全球口服脊髓灰质炎疫苗库存管理作为全球停用2型口服脊髓灰质炎疫苗后应对2型脊髓灰质炎病毒疫情的必备准备与响应机制

Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal.
PubMed 文献 · Vaccine · 2022-03-10

2015年宣布本土2型野生脊髓灰质炎病毒灭绝后,全球改用去除2型组分的口服脊髓灰质炎疫苗,并建立单价2型口服脊髓灰质炎疫苗库存以应对可能的2型脊髓灰质炎病毒疫情。随后发现的循环疫苗衍生2型脊髓灰质炎病毒疫情超出预期,补充免疫活动次数多且常未能阻断传播,使用单价2型疫苗还引发新疫情。库存管理成为应对策略关键,并逐步纳入三价口服脊髓灰质炎疫苗和基因稳定新型2型口服脊髓灰质炎疫苗。

要点

  • 全球停用2型组分后建立单价2型口服脊髓灰质炎疫苗库存以应对2型脊髓灰质炎病毒疫情。
  • 停用后发现的循环疫苗衍生2型脊髓灰质炎病毒疫情数超出预期,补充免疫活动次数多且常未阻断传播。
  • 使用单价2型疫苗在部分地区引发新疫情,需进一步使用库存疫苗,库存管理成为应对关键并持续演变。

核心结论

  • 库存管理已成为循环疫苗衍生2型脊髓灰质炎病毒疫情应对策略的关键要素,并持续演变以纳入三价口服脊髓灰质炎疫苗和基因稳定新型2型口服脊髓灰质炎疫苗。

研究设计与样本

  • 本文概述全球口服脊髓灰质炎疫苗库存管理流程及其演变,以突出相关管理挑战。

主要发现

  • 停用后最初几年检测到的疫情数超出预期,用于阻断传播的补充免疫活动次数常较多,且在许多情况下未能阻断更广泛传播。
  • 使用单价2型口服脊髓灰质炎疫苗在某些地点引发了新疫情,需要进一步使用库存疫苗。
  • 疫苗需求不可预测、生产和采购时间表固定、资源要求及多种疫苗类型共同增加了确保疫苗可用性的复杂性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Following the global declaration of indigenous wild poliovirus type 2 eradication in 2015, the world switched to oral polio vaccine (OPV) that removed the type 2 component. This 'switch' included the widespread introduction of inactivated poliovirus vaccine and the creation of a stockpile of monovalent type 2 OPV (mOPV2) to respond to potential polio virus Type 2 (PV2) outbreaks and events. With subsequent detection of outbreaks of circulating vaccine-derived poliovirus type 2 (cVDPV2), it was necessary to use this stockpile for outbreak response. Not only were more outbreaks detected than anticipated in the first few years after the switch, but the number of supplemental immunization activities (SIAs) used to stop transmission was often high, and in many cases did not stop wider transmission. Use of mOPV type 2 led in some locations to the emergence of new outbreaks that required further use of the vaccine from the stockpile. In the following years, stockpile management became a critical element of the cVDPV2 outbreak response strategy and continued to evolve to include trivalent OPV and genetically stabilized 'novel OPV type 2' vaccines in the stockpile. An overview of this process and its evolution is presented to highlight several of these management challenges. The unpredictable vaccine demand, fixed production and procurement timelines, resource requirements, and multiple vaccine types contributes to the complexity of assuring appropriate vaccine availability for this critical programmatic need to stop outbreaks.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Harutyunyan V, Quddus A, Pallansch M, et al. Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal. Vaccine. 2022. PMID: 35282924. doi:10.1016/j.vaccine.2022.02.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。